Premium Nahrungsergänzungsmittel | artgerecht

Deoxycorticosterone – Hormone, Function & Significance

Deoxycorticosterone is a naturally occurring steroid hormone produced by the adrenal cortex with mineralocorticoid activity. It regulates water and electrolyte balance and serves as a precursor to aldosterone.

Regular tips about health Regular tips about health

Things worth knowing about "Deoxycorticosterone"

Deoxycorticosterone is a naturally occurring steroid hormone produced by the adrenal cortex with mineralocorticoid activity. It regulates water and electrolyte balance and serves as a precursor to aldosterone.

What is Deoxycorticosterone?

Deoxycorticosterone (also known as desoxycorticosterone, abbreviated DOC) is a naturally occurring steroid hormone produced in the adrenal cortex. It belongs to the class of mineralocorticoids and is an important biochemical precursor to aldosterone, the most potent endogenous mineralocorticoid. Chemically, it is a C21-steroid synthesized primarily in the zona glomerulosa and zona fasciculata of the adrenal cortex.

Mechanism of Action

Deoxycorticosterone exerts its effects by binding to the mineralocorticoid receptor (MR), an intracellular nuclear receptor. Upon receptor activation, it regulates gene expression predominantly in the epithelial cells of the renal tubules. The key physiological effects include:

Promotion of sodium reabsorption in the distal renal tubules and collecting ducts
Increased potassium excretion via the urine
Enhanced water retention through osmotic effects, thereby raising blood pressure
Influence on acid-base balance through proton secretion

Compared to aldosterone, deoxycorticosterone has a considerably lower mineralocorticoid potency. However, at elevated concentrations, it can produce clinically significant effects.

Biosynthesis and Metabolism

Deoxycorticosterone is formed during adrenal steroidogenesis from progesterone via the enzyme 21-hydroxylase (CYP21A2). It is subsequently converted to corticosterone by 11β-hydroxylase (CYP11B1) and ultimately to aldosterone by aldosterone synthase (CYP11B2). Under normal physiological conditions, serum levels of deoxycorticosterone are low, but they can rise substantially in certain disease states.

Clinical Significance

Congenital Adrenal Hyperplasia (CAH)

A deficiency of 11β-hydroxylase, a rare form of congenital adrenal hyperplasia, causes a marked accumulation of deoxycorticosterone in the blood. This leads to pronounced hypertension, hypokalemia (low potassium), and suppression of the renin-angiotensin-aldosterone system. Simultaneously, cortisol deficiency drives excess ACTH production, stimulating androgen synthesis. In affected females, this can result in virilization.

Primary Hyperaldosteronism and DOC-Secreting Tumors

Rarely, DOC-secreting adrenal tumors (adenomas or carcinomas) can lead to markedly elevated deoxycorticosterone levels. The clinical picture resembles primary hyperaldosteronism, featuring hypertension and hypokalemia, but aldosterone levels are typically low or suppressed.

Pregnancy

During pregnancy, deoxycorticosterone levels rise physiologically as the placenta serves as an additional production site. These elevated levels contribute to the adaptation of maternal fluid and electrolyte homeostasis.

Diagnosis

Serum deoxycorticosterone is measured using immunoassay or mass spectrometry. Elevated levels are found in:

11β-Hydroxylase deficiency (CAH)
DOC-secreting adrenal tumors
Advanced pregnancy
Certain forms of arterial hypertension

Differential diagnosis involves measuring additional steroids (aldosterone, cortisol, ACTH), adrenal imaging, and genetic testing where appropriate.

Therapeutic Use

Deoxycorticosterone was historically one of the first mineralocorticoid preparations used in medicine, administered as deoxycorticosterone acetate (DOCA). In human medicine today, it has been largely replaced by more controllable alternatives such as fludrocortisone. In veterinary medicine, deoxycorticosterone pivalate (DOCP) is used to treat Addison disease (primary adrenocortical insufficiency) in dogs.

References

Speiser PW et al. - Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 2018.
White PC - Disorders of Aldosterone Biosynthesis and Action. New England Journal of Medicine, 1994; 331(4):250-258.
Chrousos GP - The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine, 1995; 332(20):1351-1362.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.